The cyclic GMP-dependent protein kinase II gene associates with gout disease: Identified by genome-wide analysis and case-control study

Annals of the Rheumatic Diseases

Volumn 68, Issue 7, 2009, Pages 1213-1219

  Chang, S J ^a,b   Tsai, M H ^a   Ko, Y C ^a   Tsai, P C ^c   Chen, C J ^d   Lai, H M ^d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZBROMARONE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIN GMP DEPENDENT PROTEIN KINASE II; UNCLASSIFIED DRUG; CGMP DEPENDENT PROTEIN KINASE II; CGMP-DEPENDENT PROTEIN KINASE II;

ADULT; AGED; ARTICLE; AUTOSOME; CASE CONTROL STUDY; CHROMOSOME 21; CHROMOSOME 4Q; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE; GOUT; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PEDIGREE;

ADULT; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 21; CYCLIC GMP-DEPENDENT PROTEIN KINASES; GENETIC PREDISPOSITION TO DISEASE; GOUT; HUMANS; LOD SCORE; MALE; PEDIGREE; POLYMORPHISM, GENETIC;

EID: 67549107123     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.093252     Document Type: Article

References (40)

1. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093-103.
2. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 2005;1:80-6.
3. Shadick NA, Kim R, Weiss S, Liang MH, Sparrow D, Hu H. Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study. J Rheumatol 2000;27:1708-12.
4. Chang SJ, Chang JG, Chen CJ, Wang JC, Ou TT, Chang KL, et al. Identification of a new single nucleotide substitution on the hypoxanthine-guanine phosphoribosyltransferase gene HPRTTsou from a Taiwanese aboriginal family with severe gout. J Rheumatol 1999;26:1802-7.
5. Wu CH, Lai HM, Yang MC, Liaw CC, Chang SJ, Ko YC, et al. Identification of a new single-nucleotide mutation on the hypoxanthine-guanine phosphoribosyltransferase gene from 983 cases with gout in Taiwan. J Rheumatol 2007;34:794-7.
6. Auranen M, Ala-Mello S, Turunen JA, Jarvela I. Further evidence for linkage of autosomal-dominant medullary cystic kidney disease on chromosome 1q21. Kidney Int 2001;60:1225-32.
7. Stiburkova B, Majewski J, Sebesta I, Zhang W, Ott J, Kmoch S. Familial juvenile hyperuricemic nephropathy: localization of the gene on chromosome 16p11.2- and evidence for genetic heterogeneity. Am J Hum Genet 2000;66:1989-94.
8. Gianfrancesco F, Esposito T, Ombra MN, Forabosco P, Maninchedda G, Fattorini M, et al. Identification of a novel gene and a common variant associated with uric acid nephrolithiasis in a Sardinian genetic isolate. Am J Hum Genet 2003;72:1479-91.
9. Chang SJ, Tsai PC, Chen CJ, Lai HM, Ko YC. The polymorphism -863C/A in tumour necrosis factor-alpha gene contributes an independent association to gout. Rheumatology (Oxford) 2007;46:1662-6.
10. Graessler J, Graessler A, Unger S, Kopprasch S, Tausche A-K, Kuhlisch E, et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006;54:292-300.
11. Wang WH, Chang SJ, Wang TN, Cheng LS, Feng YP, Chen CJ, et al. Complex segregation and linkage analysis of familial gout in Taiwanese aborigines. Arthritis Rheum 2004;50:242-6.
12. Cheng LS, Chiang SL, Tu HP, Chang SJ, Wang TN, Ko AM, et al. Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25. Am J Hum Genet 2004;75:498-503.
13. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421-6.
14. Chang SJ, Ko YC, Wang TN, Chang FT, Cinkotai FF, Chen CJ. High prevalence of gout and related risk factors in Taiwan's aborigines. J Rheumatol 1997;24:1364-9.
15. Chang SJ, Chen CJ, Hung HP, Ou TT, Ko YC. Community-based study in Taiwan aborigines concerning renal dysfunction in gout patients. Scand J Rheumatol 2004;33:233-8.
16. di Giovine FS, Malawista SE, Thornton E, Duff GW. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 1991;87:1375-81.
17. Meng H, Tonnesen MG, Marchese MJ, Clark RA, Bahou WF, Gruber BL. Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression. J Cell Physiol 1995;165:40-53.
18. Chapman PT, Yarwood H, Harrison AA, Stocker CJ, Jamar F, Gundel RH, et al. Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: in vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1. Arthritis Rheum 1997;40:955-65.
19. Guerne PA, Terkeltaub R, Zuraw B, Lotz M. Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 1989;32:1443-52.
20. Russell IJ, Mansen C, Kolb LM, Kolb WP. Activation of the fifth component of human complement (C5) induced by monosodium urate crystals: C5 convertase assembly on the crystal surface. Clin Immunol Immunopathol 1982;24:239-50.
21. Pouliot M, James MJ, McColl SR, Naccache PH, Cleland LG. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 1998;91:1769-76.
22. Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, Haskard DO. Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2004;50:2273-80.
23. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
24. Ghebranious N, Vaske D, Yu A, Zhao C, Marth G, Weber JL. STRP screening sets for the human genome at 5 cM density. BMC Genomics 2003;4:6.
25. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998;63:259-66.
26. Whittemore AS, Halpern J. A class of tests for linkage using affected pedigree members. Biometrics 1994;50:118-27.
27. Abreu PC, Greenberg DA, Hodge SE. Direct power comparisons between simple LOD scores and NPL scores for linkage analysis in complex diseases. Am J Hum Genet 1999;65:847-57.
28. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005;76:887-93.
29. Zhou X, Matavelli L, Frohlich ED. Uric acid: its relationship to renal hemodynamics and the renal renin-angiotensin system. Curr Hypertens Rep 2006;8:120-4.
30. Ichida K, Hosoyamada M, Kimura H, Takeda M, Utsunomiya Y, Hosoya T, et al. Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney Int 2003;63:143-55.
31. Bakhiya A, Bahn A, Burckhardt G, Wolff N. Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux. Cell Physiol Biochem 2003;13:249-56.
32. Lipkowitz MS, Leal-Pinto E, Rappoport JZ, Najfeld V, Abramson RG. Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter. J Clin Invest 2001;107:1103-15.
33. Chikuda H, Kugimiya F, Hoshi K, Ikeda T, Ogasawara T, Shimoaka T, et al. Cyclic GMP-dependent protein kinase II is a molecular switch from proliferation to hypertrophic differentiation of chondrocytes. Genes Dev 2004;18:2418-29.
34. Pfeifer A, Aszodi A, Seidler U, Ruth P, Hofmann F, Fassler R. Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science 1996;274:2082-6.
35. Landis RC, Yagnik DR, Florey O, Philippidis P, Emons V, Mason JC, et al. Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum 2002;46:3026-33.
36. Yagnik DR, Hillyer P, Marshall D, Smythe CD, Krausz T, Haskard DO, et al. Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages. Implications for the control of joint inflammation in gout. Arthritis Rheum 2000;43:1779-89.
37. Orstavik S, Solberg R, Tasken K, Nordahl M, Altherr MR, Hansson V, et al. Molecular cloning, cDNA structure, and chromosomal localization of the human type II cGMP-dependent protein kinase. Biochem Biophys Res Commun 1996;220:759-65.
38. Schneider MC, Rodriguez AM, Nomura H, Zhou J, Morton CC, Reeders ST, et al. A gene similar to PKD1 maps to chromosome 4q22: a candidate gene for PKD2. Genomics 1996;38:1-4.
39. Kimberling WJ, Fain PR, Kenyon JB, Goldgar D, Sujansky E, Gabow PA. Linkage heterogeneity of autosomal dominant polycystic kidney disease. N Engl J Med 1988;319:913-18.
40. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, Falchi M, et al. Genomewide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008;82:139-49.